GlassScriptPhysician profile
Nikunj K Patel
NPI 1659342723
$39,558.58
in general payments reported to CMS, 2019-2025
39 companies · $4,990 in 2025
The $4,990 reported for 2025 was more than what 95% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $159 · 2021: $273 · 2022: $273 · 2023: $30K · 2024: $3,406 · 2025: $4,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $30K · Food and Beverage: $4,536 · Honoraria: $2,560 · Consulting Fee: $1,000 · Gift: $41.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $30,125.53 |
| Food and Beverage | $4,536.10 |
| Honoraria | $2,560.00 |
| Consulting Fee | $1,000.00 |
| Gift | $41.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $11,815.11 | 2019-2024 | Artis Icono Floor, Magnetom Free.Max, Naeotom Alpha |
| Ge Healthcare | $11,130.77 | 2021-2025 | |
| Philips North America LLC | $10,920.71 | 2019-2025 | Is Pacs Cloud, (O47) Ei Intellispace Pacs Value Add Options, (U94) Ei Isite Pacs |
| Telix Pharmaceuticals | $3,392.97 | 2023-2025 | Illuccix |
| Fujifilm Healthcare Americas Corporation | $264.51 | 2022-2023 | Scenaria View, Oasis |
| Barco, INC. | $215.40 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $179.09 | 2019-2025 | Keytruda, Welireg |
| Daiichi Sankyo INC. | $166.70 | 2024-2025 | Enhertu, Injectafer, Vanflyta |
| Portola Pharmaceuticals, LLC | $126.35 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $121.22 | 2024 | |
| Si-Bone, INC. | $121.13 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $117.86 | 2021 | |
| Boston Scientific Corporation | $117.33 | 2022 | |
| Tersera Therapeutics LLC | $71.34 | 2024-2025 | Zoladex, Xermelo |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikunj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.